Abstract
Paralysis agitans was first documented in 1817 by James Parkinson, and therefore the syndrome was named Parkinson’s disease (PD). In fact, as early as more than 2000 years ago, the clinical manifestations of this disease have been described in Chinese medicine classics, such as the “Huangdi Neijing (Yellow Emperor’s Internal Classic)” and “Zhong Zang Jing (Hua’s Zhong Zang Classic).” In recent years, especially in the past 30 years after reform and opening-up, PD has drawn a lot of attention by Chinese scholars. Although great progress in the studies of PD has been made in recent years, the gap between China and western countries still exists. In this review, we concentrate on the main progress made in epidemic characteristics, etiology, diagnosis and management of PD in China.

Similar content being viewed by others
References
Zhang ZX, Dong ZH, Román GC (2006) Early descriptions of Parkinson disease in ancient China. Arch Neurol 63:782–784
Li SC, Schoenberg BS, Wang CC et al (1985) A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China. Arch Neurol 42:655–657
Shi YM, Wang GQ, Xue GB et al (1987) Study on the prevalence of Parkinson disease in Hongkou district, Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 8:205–207
Wang YS, Shi YM, Wu ZY et al (1991) Parkinson’s disease in China. Coordinational group of Neuroepidemiology, PLA. Chin Med J 104:960–964
Ho SC, Woo J, Lee CM (1989) Epidemiologic study of Parkinson’s disease in Hong Kong. Neurology 39:1314–1318
Wang SJ, Fuh JL, Teng EL et al (1996) A door-to-door survey of Parkinson’s disease in a Chinese population in Kinmen. Arch Neurol 53:66–71
Chen RC, Chang SF, Su CL et al (2001) Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology 57:1679–1686
Tan LC, Venketasubramanian N, Hong CY et al (2004) Prevalence of Parkinson disease in Singapore: Chinese vs. Malays vs. Indians. Neurology 62:1999–2004
Zhang ZX, Roman GC, Hong Z et al (2005) Parkinson’s disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 365:595–597
Zhang L, Nie ZY, Liu Y et al (2005) The prevalence of PD in a nutritionally deficient rural population in China. Acta Neurol Scand 112:29–35
Tanner CM, Chen B, Wang W et al (1989) Environmental factors and Parkinson’s disease: a case–control study in China. Neurology 39:660–664
Tanner CM, Chen B, Wang WZ et al (1987) Environmental factors in the etiology of Parkinson’s disease. Can J Neurol Sci 14(3 Suppl):419–423
Chan DK, Woo J, Ho SC et al (1998) Genetic and environmental risk factors for Parkinson’s disease in a Chinese population. J Neurol Neurosurg Psychiatry 65:781–784
Tan EK, Tan C, Fook-Chong SM et al (2003) Dose-dependent protective effect of coffee, tea, and smoking in Parkinson’s disease: a study in ethnic Chinese. J Neurol Sci 216:163–167
Tan LC, Koh WP, Yuan JM et al (2008) Differential effects of black versus green tea on risk of Parkinson’s disease in the Singapore Chinese Health Study. Am J Epidemiol 67:553–560
Ma L, Zhang L, Gao XH et al (2006) Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case–control study. Acta Neurol Scand 113:278–281
Wakabayashi K, Takahashi H (2007) Pathology of familial Parkinson’s disease. Brain Nerve 59:851–864
Polymeropoulos MH, Higgins JJ, Golbe LI et al (1996) Mapping of a gene for Parkinson’s disease to chromosome 4q21–q23. Science 274:1197–1199
Chan DK, Mellick G, Cai H et al (2000) The alpha-synuclein gene and Parkinson disease in a Chinese population. Arch Neurol 57:501–503
Hu CJ, Sung SM, Liu H et al (1999) No mutation of G209A in the alpha-synuclein gene in sporadic Parkinson’s disease among Taiwan Chinese. Eur Neurol 41:85–87
Lin JJ, Yueh KC, Chang DC et al (1999) Absence of G209A and G88C mutations in the alpha-synuclein gene of Parkinson’s disease in a Chinese population. Eur Neurol 42:217–220
Tan EK, Chai A, Teo YY et al (2004) Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease. Neurology 62(1):128–131
Zhao XP, Zheng HM, Xie HJ et al (2004) The alpha-synuclein gene microsatellite polymorphism and lateonset sporadic Parkinson’s disease susceptibility. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21:339–341
Fung HC, Chen CM, Hardy J et al (2006) A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan. BMC Neurol 6:47
An XK, Peng R, Li T et al (2008) LRRK2 Gly2385Arg variant is a risk factor of Parkinson’s disease among Han-Chinese from Mainland China. Eur J Neurol 15:301–305
Chan DK, Ng PW, Mok V et al (2008) LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson’s disease compared to late-onset patients. J Neural Transm 115:1275–1277
Li C, Ting Z, Qin X et al (2007) The prevalence of LRRK2 Gly2835Arg variant in Han Chinese population with Parkinson’s disease. Mov Disord 22:2439–2443
Ross OA, Wu YR, Lee MC et al (2008) Analysis of LRRK2 R1628P as a risk factor for Parkinson’s disease. Ann Neurol 64:88–92
Lu CS, Wu-Chan YH, Van Doeselaar M et al (2008) The LRRK2 Arg1628Pro variant is a risk factor for Parkinson’s disease in the Chinese population. Neurogenetics 9:271–276
Wu T, Zeng Y, Ding X et al (2006) A novel P755L mutation in LRRK2 gene associated with Parkinson’s disease. Neuroreport 17:1859–1862
Hao YX, Zhang J, Fang CP et al (2008) Association of two polymorphisms in ubiquitin carboxy-terminal hydrolase-L1 gene with Parkinson’s disease in Shanghai. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 25:272–275
Wang J, Zhao CY, Si YM et al (2002) ACT and UCH-L1 polymorphisms in Parkinson’s disease and age of onset. Mov Disord 17:767–771
Xiao Y, Zhang B (2008) Association of the ubiquitin carboxy-terminal hydrolase-L1 genetic polymorphism with the susceptibility of Parkinson’s disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25:586–587
Zhang ZJ, Burgunder JM, An XK et al (2008) Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson’s disease in a Han-Chinese population. Neurosci Lett 442:200–202
Chan DK, Mok V, Ng PW et al (2008) PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson’s disease. J Neural Transm 115:715–719
Shyu WC, Lin SZ, Chiang MF et al (2005) Early-onset Parkinson’s disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study. Parkinsonism Relat Disord 11(3):173–180
Wu RM, Bounds R, Lincoln S et al (2005) Parkin mutations and early-onset parkinsonism in a Taiwanese cohort. Arch Neurol 62:82–87
Wu RM, Shan DE, Sun CM et al (2002) Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations. Mov Disord 17:670–675
Tan EK, Puong KY, Chan DK et al (2005) Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association. Hum Genet 118:484–488
Taylor JM, Wu RM, Lin CH et al (2009) Lack of evidence for association of a parkin promoter polymorphism with early-onset Parkinson’s disease in a Chinese population. Parkinsonism Relat Disord 15:149–152
Peng R, Gou Y, Yuan Q et al (2003) Mutation screening and association analysis of the parkin gene in Parkinson’s disease patients from South-West China. Eur Neurol 49:85–89
Wang F, Chen B, Feng XL et al (2007) PINK1 IVS5–5 G>A polymorphism may contribute to the risk of late onset Parkinson disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:305–309
Wang F, Feng X, Ma J et al (2006) A common A340T variant in PINK1 gene associated with late-onset Parkinson’s disease in Chinese. Neurosci Lett 410:121–125
Chan DK, Mellick GD, Buchanan DD et al (2002) Lack of association between CYP1A1 polymorphism and Parkinson’s disease in a Chinese population. J Neural Transm 109:35–39
Wang J, Liu Z, Chan P (2000) Lack of association between cytochrome P450 2E1 gene polymorphisms and Parkinson’s disease in a Chinese population. Mov Disord 15:1267–1269
Chan DK, Lam MK, Wong R et al (2003) Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese. Neurology 60:1002–1005
Lee CG, Tang K, Cheung YB et al (2004) MDR1, the blood-brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese. J Med Genet 41:e60
Tang G, Zhang M, Xie H et al (2002) Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer’s disease and Parkinson’s disease. Neurosci Lett 328:195–197
Tang G, Xie H, Xu L et al (2002) Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet 114:446–449
Jiang G, Xu L, Wang L et al (2008) Association study of human MTH1 Ile45Thr polymorphism with sporadic Parkinson’s disease. Eur Neurol 59:15–17
Han Y, Zhang XH, Chen T et al (2008) The survey for the diagnosis and treatment of Parkinson’s disease. Zhonghua Bao Jian Yi Xue Za Zhi 10:18–20
Zhang ZX (The Group of Movement disorders and Parkinson’s disease, Neurologic Branch of Chinese Medical Association) (2006) The diagnosis of Parkinson’s disease. Zhonghua Shen Jing Ke Za Zhi 39: 408–409
Feng F, You H, Wang H et al (2009) Phase-weighted imaging in differentiating multiple system atrophy from idiopathic Parkinson disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 31:129–133
Chen SD (The Group of Movement Disorders and Parkinson’s Disease, Neurologic Branch of Chinese Medical Association) (2006) The guideline for management of Parkinson’s disease. Zhonghua Shen Jing Ke Za Zhi 39:409–412
Wang X, Liang XB, Li FQ et al (2008) Therapeutic strategies for Parkinson’s disease: the ancient meets the future—traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochem Res 33:1956–1963
Li JY, Yang MH, Dou YQ et al (2008) TCM therapy for Parkinson’s disease. Beijing Zhong Yi Xue Za Zhi 27:300–302
Ren XM (2008) Fifty cases of Parkinson’s disease treated by acupuncture combined with madopar. J Tradit Chin Med 28:255–257
Liang XB, Liu XY, Li FQ et al (2002) Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Res Mol Brain Res 108:51–59
Lam YC, Kum WF, Durairajan SS et al (2008) Efficacy and safety of acupuncture for idiopathic Parkinson’s disease: a systematic review. J Altern Complement Med 14:663–671
Sun B, Lang LQ, Cong PY et al (2001) History of Chinese stereotactic and functional neurosurgery. Stereotact Funct Neurosurg 717:17–19
Iacono RP, Tang ZS, Mazziotta JC et al (1992) Bilateral fetal grafts for Parkinson’s disease: 22 months’ results. Stereotact Funct Neurosurg 58:84–87
Liu J, Huang HY (2007) How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson’s disease? Neurosci Bull 23:377–382
Zhang ZX, Anderson DW, Huang JB et al (2003) Prevalence of Parkinson’s disease and related disorders in the elderly population of greater Beijing, China. Mov Disord 18:764–772
Woo J, Lau E, Ziea E et al (2004) Prevalence of Parkinson’s disease in a Chinese population. Acta Neurol Scand 109:228–231
Acknowledgments
This work was supported by the Key Project for Science and Technology Development Fund of Nanjing Medical University (08NMUZ040) and the Scholarship for Studying Abroad of Jiangsu Provincial Government.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tian, Yy., Tang, Cj., Wu, J. et al. Parkinson’s disease in China. Neurol Sci 32, 23–30 (2011). https://doi.org/10.1007/s10072-010-0461-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-010-0461-8